Tricida Inc (NASDAQ:TCDA)
| 4.73 Delayed Data As of Mar 05 |  +0.21 / +4.65%Today’s Change | 3.74 Today|||52-Week Range 33.94 | -32.91% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $238.2M |
Company Description
Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker in 2013 and is headquartered in South San Francisco, CA.
Contact Information
Tricida, Inc. 7000 Shoreline Court South San Francisco California 94080 |
Employees
Shareholders
| Other institutional | 55.20% |
| Individual stakeholders | 45.40% |
| Mutual fund holders | 17.31% |
Top Executives
| Gerrit Klaerner | President, Chief Executive Officer & Director |
| Geoffrey M. Parker | Executive VP, Chief Operating & Financial Officer |
| Wilhelm Stahl | Chief Technology Officer & Senior Vice President |
| Dawn Parsell | Executive Vice President-Clinical Development |
| Elizabeth A. Faust | Executive Vice President-Medical Affairs |
